Frontlight ResearchEarly access
Trial site
Xiamen Hospital of T.C.M.
- 5running trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)1 trial
- High blood pressure1 trial
- Liver cirrhosis1 trial
- Primary biliary cholangitis1 trial
- Pulmonary arterial hypertension1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 1/21 trial
- Phase 21 trial
- Phase 31 trial
- Phase 41 trial
- Status
- Not yet recruiting2 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Cascade Pharmaceuticals, Inc2 trials
- ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.1 trial
- Nanjing First Hospital, Nanjing Medical University1 trial
- Peking University First Hospital1 trial
Running trials
Not yet recruiting
Recruiting
Recruiting
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Active, not recruiting
Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH)
Not yet recruiting
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure1 recruiting
- Liver cirrhosis1 recruiting
- Primary biliary cholangitis1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Type 1 diabetes1 recruiting
Site data: ClinicalTrials.govUpdated 13 Nov 2026